Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls

Cancer

Volumn 119, Issue 3, 2013, Pages 621-628

  Vadaparampil, Susan T ^a,b   Staras, Stephanie A S ^c   Malo, Teri L ^a   Eddleton, Katie Z ^c   Christie, Juliette ^a   Rodriguez, Maria ^a   Giuliano, Anna R ^a,b   Shenkman, Elizabeth A ^c,d  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Department of Clinical and Health Psychology   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

cancer vaccine; cervix cancer; HPV vaccine; human papillomavirus; low income population; Medicaid; physician

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CHILD; FEMALE; GENERAL PRACTITIONER; GYNECOLOGIST; HEALTH CARE DISPARITY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; LOWEST INCOME GROUP; MALE; MEDICAID; PAPILLOMAVIRUS INFECTION; PATIENT REFERRAL; PEDIATRICIAN; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; WART VIRUS;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; ADULT; AGED; ALPHAPAPILLOMAVIRUS; CAUSALITY; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION PROGRAMS; MALE; MASS VACCINATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PHYSICIAN'S ROLE; POVERTY;

EID: 84872945707     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27735     Document Type: Article

References (40)

1. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV,. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55: 244-265.
2. Paavonen J, Lehtinen M,. Introducing human papillomavirus vaccines-questions remain. Ann Med. 2008; 40: 162-166.
3. American Cancer Society. How many women get cancer of the cervix? http://www.cancer.org/Cancer/CervicalCancer/OverviewGuide/cervical-cancer- overview-key-statistics. Accessed June 28, 2011.
4. Healthy People 2020. Sexually transmitted diseases. http://www. healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?top icId=37 Accessed June 23, 2011.
5. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER,; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56 (RR-2): 1-24.
6. McDougall JA, Madeleine MM, Daling JR, Li CI,. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control. 2007; 18: 1175-1186.
7. Parikh S, Brennan P, Boffetta P,. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003; 105: 687-691.
8. Singh GK, Miller BA, Hankey BF, Edwards BK,. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004; 101: 1051-1057.
9. O'Malley CD, Shema SJ, Clarke LS, Clarke CA, Perkins CI,. Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health. 2006; 96: 2179-2185.
10. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 1117-1123.
11. Staras SA, Vadaparampil ST, Haderxhanaj LT, Shenkman EA,. Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008. J Adolesc Health. 2010; 47: 381-388.
12. Dempsey A, Cohn L, Dalton V, Ruffin M,. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine. 2011; 29: 528-534.
13. Cook RL, Zhang J, Mullins J, et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010; 47: 596-599.
14. Biro FM, Rosenthal SL, Rymarquis L, Kollar LM, Hillard PJ,. Adolescent girls' understanding of Papanicolaou smear results. J Pediatr Adolesc Gynecol. 1997; 10: 209-212.
15. Burak LJ, Meyer M,. Using the Health Belief Model to examine and predict college women's cervical cancer screening beliefs and behavior. Health Care Women Int. 1997; 18: 251-262.
16. Pitts M, Clarke T,. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res. 2002; 17: 706-714.
17. Mays RM, Zimet GD, Winston Y, Kee R, Dickes J, Su L,. Human papillomavirus, genital warts, Pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int. 2000; 21: 361-374.
18. Horn JE, McQuillan GM, Ray PA, Hook EW 3rd,. Reproductive health practices in women attending an inner-city STD clinic. Sex Transm Dis. 1990; 17: 133-137.
19. Jubelirer SJ, Blanton MF, Blanton PD, et al. Assessment of knowledge, attitudes, and behaviors relative to cervical cancer and the Pap smear among adolescent girls in West Virginia. J Cancer Educ. 1996; 11: 230-232.
20. Nugent LS, Tamlyn-Leaman K,. The colposcopy experience: what do women know? J Adv Nurs. 1992; 17: 514-520.
21. Ramirez JE, Ramos DM, Clayton L, Kanowitz S, Moscicki AB,. Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health. 1997; 6: 113-121.
22. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT,. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009; 18: 363-372.
23. Caskey R, Lindau ST, Alexander GC,. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009; 45: 453-462.
24. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD,. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine. 2011; 29: 890-895.
25. Guerry SL, De Rosa CJ, Markowitz LE, et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 2011; 29: 2235-2241.
26. Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health. 2009; 45: 430-437.
27. Vadaparampil ST, Kahn JA, Salmon D, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine. 2011; 29: 8634-8641.
28. Dillman D,. Mail and Internet Surveys: The Tailored Design Method. New York, NY: Wiley; 2000.
29. Lindley MC, Smith PJ, Rodewald LE,. Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009. Public Health Rep. 2011; 126: 124-134.
30. Bartlett JA, Peterson JA,. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs. 2011; 27: 434-446.
31. Chao C, Velicer C, Slezak JM, Jacobsen SJ,. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010; 171: 357-367.
32. Szilagyi PG, Rodewald LE, Humiston SG, et al. Missed opportunities for childhood vaccinations in office practices and the effect on vaccination status. Pediatrics. 1993; 91: 1-7.
33. Fiks AG, Hunter KF, Localio AR, Grundmeier RW, Alessandrini EA,. Impact of immunization at sick visits on well-child care. Pediatrics. 2008; 121: 898-905.
34. Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG,. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007; 161: 252-259.
35. Oster NV, McPhillips-Tangum CA, Averhoff F, Howell K,. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract. 2005; 18: 13-19.
36. Centers for Disease Control and Prevention. Vaccines for Children Program (VFC). http://www.cdc.gov/vaccines/programs/vfc/default. htm. Accessed November 4, 2011.
37. National Cancer Institute. NCI Fact Sheet: Cancer Health Disparities. http://www.cancer.gov/cancertopics/factsheet/disparities/cancer-health- disparities. Accessed January 6, 2012.
38. US Food and Drug Administration. FDA approves new indication for Gardasil to prevent genital warts in men and boys. http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm187003.htm. Accessed August 17, 2011.
39. Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD,. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health. 2010; 47: 3-11.
40. Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60: 1705-1708.